Associate Director
Akebia Therapeutics
Associate Director
Akebia Therapeutics
Develops CKD anemia therapies
The Associate Director, Regulatory Operations is a hands-on leader who will shape how Akebia plans, produces, submits, and manages regulatory information. In addition to leading timely, high-quality global submissions, this role will have meaningful influence over the processes, standards, and systems that enable Regulatory Affairs to operate effectively.
The successful candidate will establish scalable ways of working, strengthen document governance across SharePoint and Veeva RIM, help lead the company's readiness for eCTD 4.0, and introduce practical tools and reporting that make the Regulatory team's priorities, progress, and impact visible across the company. This opportunity is well suited to someone who enjoys combining submission expertise with systems thinking, change leadership, and hands-on execution.
This role is based in Waltham, MA in a hybrid model. Applicants must be able to come to office on a regular basis. The role reports to the Senior Director, Regulatory Affairs.
Key Responsibilities:
Strategic Leadership and Process Design
Submission Operations and eCTD readiness
Information Governance and Regulatory Systems
Operational Visibility and Continuous Improvement
Perform other Regulatory Operations duties as assigned
Skills & Experience
Required Qualifications:
Base Compensation for this role will depend on a number of factors including a candidate’s qualifications, skills, competencies, and experience, and may fall outside of the range shown. Base pay is only one component of the company’s total rewards package, all regular employees are also eligible for the corporate bonus program or the incentive compensation program (if applicable), as well as equity. Additional benefits include health care, vision, dental, retirement, PTO, etc.
Targeted Base Salary 167650 - 207098 USD
Develops CKD anemia therapies
Akebia Therapeutics focuses on developing and commercializing therapies for chronic kidney disease (CKD), especially anemia related to CKD. Its lead product candidate, vadadustat, is in global Phase 3 trials. The company conducts research, clinical development, and strategic partnerships to bring therapies to market, generating revenue from product sales, licensing, and collaborations. Akebia's goal is to improve the quality of life for CKD patients by providing effective treatments through a science-driven biopharmaceutical approach based in Cambridge, MA.
Explore more opportunities at Akebia Therapeutics